ERBB2 and breast carcinoma: A current study analyzed the expression profile of lncRNAs including DPP10-AS1 in breast cancer and provide useful information for exploring candidate therapeutic targets and new molecular biomarkers for HER-2-enriched subtype breast cancer [8] represent noncoding RNAs capable of regulating the expression of target mRNAs and are mediated by both tumor suppressors and promoters [9].